Showing results (41-50 of 64) with videos related to
Sort By:
Pageof 7
European Journal of Medical Research|January 4, 2026
Effects of prophylactic constant-rate infusion of norepinephrine or phenylephrine on neonatal outcomes during caesarean sectionWenhui Tao, Jinfeng Bao, Qing Wang, et al.Bioorganic & Medicinal Chemistry Letters|July 23, 2015
Discovery of substituted (4-phenyl-1H-imidazol-2-yl)methanamine as potent somatostatin receptor 3 agonistsZhong Lai, Shuwen He, Edward C Sherer, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Stimulation of Glucose-Dependent Insulin Secretion by a Potent, Selective sst3 AntagonistAlexander Pasternak, Zhe Feng, Reynalda de Jesus, et al.Bioorganic & Medicinal Chemistry Letters|March 30, 2010
Synthesis and SAR of heterocyclic carboxylic acid isosteres based on 2-biarylethylimidazole as bombesin receptor subtype-3 (BRS-3) agonists for the treatment of obesityMark Hadden, Allan Goodman, Cheng Guo, et al.ACS Medicinal Chemistry Letters|June 20, 2014
Diamine Derivatives as Novel Small-Molecule, Potent, and Subtype-Selective Somatostatin SST3 Receptor AgonistsDerun Li, Zhicai Wu, Yang Yu, et al.Journal of Medicinal Chemistry|March 3, 2017
Microscale High-Throughput Experimentation as an Enabling Technology in Drug Discovery: Application in the Discovery of (Piperidinyl)pyridinyl-1H-benzimidazole Diacylglycerol Acyltransferase 1 InhibitorsTim Cernak, Nathan J Gesmundo, Kevin Dykstra, et al.Bioorganic & Medicinal Chemistry Letters|July 13, 2010
Discovery of potent, selective, and orally bioavailable 3H-spiro[isobenzofuran-1,4'-piperidine] based melanocortin subtype-4 receptor agonistsLiangqin Guo, Zhixiong Ye, Jian Liu, et al.Bioorganic & Medicinal Chemistry Letters|July 6, 2010
Spiroindane based amides as potent and selective MC4R agonists for the treatment of obesityShuwen He, Zhixiong Ye, Peter H Dobbelaar, et al.Journal of Medicinal Chemistry|July 25, 2025
Discovery of Gut-Targeted GPR40 Agonist K-757 and GPR119 Agonist K-833, a Combination Treatment for Metabolic DisordersChristopher R Moyes, Shuwen He, Simon Mathieu, et al.Bioorganic & Medicinal Chemistry Letters|March 29, 2011
Discovery of a piperazine urea based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor partial agonistQingmei Hong, Raman K Bakshi, Brenda L Palucki, et al.Pageof 7